Member States ‘Inch Closer’ to Pandemic Agreement; WHO Officials Sound Cautiously Optimistic Note 21/05/2024 Elaine Ruth Fletcher Senior WHO officials sounded a cautiously optimistic note Tuesday about the prospects for WHO member states to somehow wrap up down-to-the-wire negotiations on a landmark Pandemic Accord in time to submit a final agreement to the World Health Assembly, which begins next Monday, 27 May. Meanwhile, they heralded the milestone agreement “in principle” to amend […] Continue reading -> WHO Updates List of Most Threatening Drug-Resistant Bacteria as Pharma Warns New Antibiotic Pipeline is Inadequate 17/05/2024 Kerry Cullinan The World Health Organization (WHO) has updated its list of antibiotic-resistant bacteria that pose the greatest threat to human health, ranking the 15 families of bacteria that feature as “critical”, “high” and “medium” threats. The Bacterial Priority Pathogens List (BPPL) 2024’s “critical” list features bacteria that are high burden, can resist treatment and spread resistance […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> WHO Issues First-Ever List of Antimicrobials with Category “For Use in Humans Only” 13/02/2024 Sophia Samantaroy The WHO has released a first-ever list of 21 antimicrobials earmarked as “authorized for use in humans only” – a first for the organization in its efforts to protect overuse and abuse of critical first-line drugs that need to be protected by overuse in animal and plant health sectors – and consequent antimicrobial resistance (AMR). […] Continue reading -> Tuberculosis and Inequality: How Race, Caste, and Class Impact Access to Medicines 16/12/2023 Maayan Hoffman The elimination of tuberculosis cannot be achieved if medicines are locked in a “patent panoply,” according to Indian author and journalist Vidya Kishnan. Speaking to Garry Aslanyan on the most recent episode of Dialogues, a new series from the Global Health Matters podcast, the author of “Phantom Plague: How Tuberculosis Shaped History” said that “everything […] Continue reading -> A Third of People Used Antibiotics Without Prescription, WHO Europe Survey Finds 23/11/2023 Kerry Cullinan One-third of people in 14 countries in the Western Balkans, the Caucasus and Central Asia used antibiotics without a medical prescription, according to a survey released on Wednesday by the World Health Organization’s (WHO) European Region. The survey involved 8221 participants, half of whom reported taking oral antibiotics in the past 12 months. Participants came […] Continue reading -> New Gonorrhoea Treatment Shows Positive Results in Trial Sponsored by Non-Profit Partnership 02/11/2023 Kerry Cullinan The world may soon have a new antibiotic to treat gonorrhoea after a successful phase 3 trial of an oral pill, zoliflodacin, that was led and sponsored by a non-profit organisation. The results were announced late Wednesday by the Global Antibiotic Research and Development Partnership (GARDP), which conducted the trial in collaboration with Innoviva Specialty […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Updates List of Most Threatening Drug-Resistant Bacteria as Pharma Warns New Antibiotic Pipeline is Inadequate 17/05/2024 Kerry Cullinan The World Health Organization (WHO) has updated its list of antibiotic-resistant bacteria that pose the greatest threat to human health, ranking the 15 families of bacteria that feature as “critical”, “high” and “medium” threats. The Bacterial Priority Pathogens List (BPPL) 2024’s “critical” list features bacteria that are high burden, can resist treatment and spread resistance […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> WHO Issues First-Ever List of Antimicrobials with Category “For Use in Humans Only” 13/02/2024 Sophia Samantaroy The WHO has released a first-ever list of 21 antimicrobials earmarked as “authorized for use in humans only” – a first for the organization in its efforts to protect overuse and abuse of critical first-line drugs that need to be protected by overuse in animal and plant health sectors – and consequent antimicrobial resistance (AMR). […] Continue reading -> Tuberculosis and Inequality: How Race, Caste, and Class Impact Access to Medicines 16/12/2023 Maayan Hoffman The elimination of tuberculosis cannot be achieved if medicines are locked in a “patent panoply,” according to Indian author and journalist Vidya Kishnan. Speaking to Garry Aslanyan on the most recent episode of Dialogues, a new series from the Global Health Matters podcast, the author of “Phantom Plague: How Tuberculosis Shaped History” said that “everything […] Continue reading -> A Third of People Used Antibiotics Without Prescription, WHO Europe Survey Finds 23/11/2023 Kerry Cullinan One-third of people in 14 countries in the Western Balkans, the Caucasus and Central Asia used antibiotics without a medical prescription, according to a survey released on Wednesday by the World Health Organization’s (WHO) European Region. The survey involved 8221 participants, half of whom reported taking oral antibiotics in the past 12 months. Participants came […] Continue reading -> New Gonorrhoea Treatment Shows Positive Results in Trial Sponsored by Non-Profit Partnership 02/11/2023 Kerry Cullinan The world may soon have a new antibiotic to treat gonorrhoea after a successful phase 3 trial of an oral pill, zoliflodacin, that was led and sponsored by a non-profit organisation. The results were announced late Wednesday by the Global Antibiotic Research and Development Partnership (GARDP), which conducted the trial in collaboration with Innoviva Specialty […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> WHO Issues First-Ever List of Antimicrobials with Category “For Use in Humans Only” 13/02/2024 Sophia Samantaroy The WHO has released a first-ever list of 21 antimicrobials earmarked as “authorized for use in humans only” – a first for the organization in its efforts to protect overuse and abuse of critical first-line drugs that need to be protected by overuse in animal and plant health sectors – and consequent antimicrobial resistance (AMR). […] Continue reading -> Tuberculosis and Inequality: How Race, Caste, and Class Impact Access to Medicines 16/12/2023 Maayan Hoffman The elimination of tuberculosis cannot be achieved if medicines are locked in a “patent panoply,” according to Indian author and journalist Vidya Kishnan. Speaking to Garry Aslanyan on the most recent episode of Dialogues, a new series from the Global Health Matters podcast, the author of “Phantom Plague: How Tuberculosis Shaped History” said that “everything […] Continue reading -> A Third of People Used Antibiotics Without Prescription, WHO Europe Survey Finds 23/11/2023 Kerry Cullinan One-third of people in 14 countries in the Western Balkans, the Caucasus and Central Asia used antibiotics without a medical prescription, according to a survey released on Wednesday by the World Health Organization’s (WHO) European Region. The survey involved 8221 participants, half of whom reported taking oral antibiotics in the past 12 months. Participants came […] Continue reading -> New Gonorrhoea Treatment Shows Positive Results in Trial Sponsored by Non-Profit Partnership 02/11/2023 Kerry Cullinan The world may soon have a new antibiotic to treat gonorrhoea after a successful phase 3 trial of an oral pill, zoliflodacin, that was led and sponsored by a non-profit organisation. The results were announced late Wednesday by the Global Antibiotic Research and Development Partnership (GARDP), which conducted the trial in collaboration with Innoviva Specialty […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> WHO Issues First-Ever List of Antimicrobials with Category “For Use in Humans Only” 13/02/2024 Sophia Samantaroy The WHO has released a first-ever list of 21 antimicrobials earmarked as “authorized for use in humans only” – a first for the organization in its efforts to protect overuse and abuse of critical first-line drugs that need to be protected by overuse in animal and plant health sectors – and consequent antimicrobial resistance (AMR). […] Continue reading -> Tuberculosis and Inequality: How Race, Caste, and Class Impact Access to Medicines 16/12/2023 Maayan Hoffman The elimination of tuberculosis cannot be achieved if medicines are locked in a “patent panoply,” according to Indian author and journalist Vidya Kishnan. Speaking to Garry Aslanyan on the most recent episode of Dialogues, a new series from the Global Health Matters podcast, the author of “Phantom Plague: How Tuberculosis Shaped History” said that “everything […] Continue reading -> A Third of People Used Antibiotics Without Prescription, WHO Europe Survey Finds 23/11/2023 Kerry Cullinan One-third of people in 14 countries in the Western Balkans, the Caucasus and Central Asia used antibiotics without a medical prescription, according to a survey released on Wednesday by the World Health Organization’s (WHO) European Region. The survey involved 8221 participants, half of whom reported taking oral antibiotics in the past 12 months. Participants came […] Continue reading -> New Gonorrhoea Treatment Shows Positive Results in Trial Sponsored by Non-Profit Partnership 02/11/2023 Kerry Cullinan The world may soon have a new antibiotic to treat gonorrhoea after a successful phase 3 trial of an oral pill, zoliflodacin, that was led and sponsored by a non-profit organisation. The results were announced late Wednesday by the Global Antibiotic Research and Development Partnership (GARDP), which conducted the trial in collaboration with Innoviva Specialty […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Issues First-Ever List of Antimicrobials with Category “For Use in Humans Only” 13/02/2024 Sophia Samantaroy The WHO has released a first-ever list of 21 antimicrobials earmarked as “authorized for use in humans only” – a first for the organization in its efforts to protect overuse and abuse of critical first-line drugs that need to be protected by overuse in animal and plant health sectors – and consequent antimicrobial resistance (AMR). […] Continue reading -> Tuberculosis and Inequality: How Race, Caste, and Class Impact Access to Medicines 16/12/2023 Maayan Hoffman The elimination of tuberculosis cannot be achieved if medicines are locked in a “patent panoply,” according to Indian author and journalist Vidya Kishnan. Speaking to Garry Aslanyan on the most recent episode of Dialogues, a new series from the Global Health Matters podcast, the author of “Phantom Plague: How Tuberculosis Shaped History” said that “everything […] Continue reading -> A Third of People Used Antibiotics Without Prescription, WHO Europe Survey Finds 23/11/2023 Kerry Cullinan One-third of people in 14 countries in the Western Balkans, the Caucasus and Central Asia used antibiotics without a medical prescription, according to a survey released on Wednesday by the World Health Organization’s (WHO) European Region. The survey involved 8221 participants, half of whom reported taking oral antibiotics in the past 12 months. Participants came […] Continue reading -> New Gonorrhoea Treatment Shows Positive Results in Trial Sponsored by Non-Profit Partnership 02/11/2023 Kerry Cullinan The world may soon have a new antibiotic to treat gonorrhoea after a successful phase 3 trial of an oral pill, zoliflodacin, that was led and sponsored by a non-profit organisation. The results were announced late Wednesday by the Global Antibiotic Research and Development Partnership (GARDP), which conducted the trial in collaboration with Innoviva Specialty […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Tuberculosis and Inequality: How Race, Caste, and Class Impact Access to Medicines 16/12/2023 Maayan Hoffman The elimination of tuberculosis cannot be achieved if medicines are locked in a “patent panoply,” according to Indian author and journalist Vidya Kishnan. Speaking to Garry Aslanyan on the most recent episode of Dialogues, a new series from the Global Health Matters podcast, the author of “Phantom Plague: How Tuberculosis Shaped History” said that “everything […] Continue reading -> A Third of People Used Antibiotics Without Prescription, WHO Europe Survey Finds 23/11/2023 Kerry Cullinan One-third of people in 14 countries in the Western Balkans, the Caucasus and Central Asia used antibiotics without a medical prescription, according to a survey released on Wednesday by the World Health Organization’s (WHO) European Region. The survey involved 8221 participants, half of whom reported taking oral antibiotics in the past 12 months. Participants came […] Continue reading -> New Gonorrhoea Treatment Shows Positive Results in Trial Sponsored by Non-Profit Partnership 02/11/2023 Kerry Cullinan The world may soon have a new antibiotic to treat gonorrhoea after a successful phase 3 trial of an oral pill, zoliflodacin, that was led and sponsored by a non-profit organisation. The results were announced late Wednesday by the Global Antibiotic Research and Development Partnership (GARDP), which conducted the trial in collaboration with Innoviva Specialty […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
A Third of People Used Antibiotics Without Prescription, WHO Europe Survey Finds 23/11/2023 Kerry Cullinan One-third of people in 14 countries in the Western Balkans, the Caucasus and Central Asia used antibiotics without a medical prescription, according to a survey released on Wednesday by the World Health Organization’s (WHO) European Region. The survey involved 8221 participants, half of whom reported taking oral antibiotics in the past 12 months. Participants came […] Continue reading -> New Gonorrhoea Treatment Shows Positive Results in Trial Sponsored by Non-Profit Partnership 02/11/2023 Kerry Cullinan The world may soon have a new antibiotic to treat gonorrhoea after a successful phase 3 trial of an oral pill, zoliflodacin, that was led and sponsored by a non-profit organisation. The results were announced late Wednesday by the Global Antibiotic Research and Development Partnership (GARDP), which conducted the trial in collaboration with Innoviva Specialty […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Gonorrhoea Treatment Shows Positive Results in Trial Sponsored by Non-Profit Partnership 02/11/2023 Kerry Cullinan The world may soon have a new antibiotic to treat gonorrhoea after a successful phase 3 trial of an oral pill, zoliflodacin, that was led and sponsored by a non-profit organisation. The results were announced late Wednesday by the Global Antibiotic Research and Development Partnership (GARDP), which conducted the trial in collaboration with Innoviva Specialty […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> Posts navigation Older postsNewer posts